{"title":"尼日利亚南部哈科特港受艾滋病毒感染女孩的青春期发育模式","authors":"Azubogu U. S., Ugwu R. O., Jaja T., Alikor E. A.","doi":"10.9734/jamps/2023/v25i12660","DOIUrl":null,"url":null,"abstract":"Background: Unidentified and untreated pubertal abnormalities in HIV-infected girls may result in adverse psychosocial consequences as well as a reduced final adult height. The aim of the study was to determine the pubertal development pattern in HIV-infected girls receiving care in two tertiary hospitals in Port Harcourt, Southern Nigeria. \nMaterials and Methods: This was a comparative cross-sectional study involving 90 HIV-infected girls aged 10-18 years and 90 age, sex and socio-economic class matched non-HIV-infected girls. \nResults: The mean age of pubertal onset in HIV-infected girls was 11.57±1.05 which was significantly higher than the mean age of 10.78±0.69 seen in the non-HIV-infected group (ꭓ 2= 2.667, p=0.011). Sixty three (70%) of HIV-infected females had commenced puberty (Tanner stage 2 or above for breast development) compared to 83 (92.2%) of non-HIV-infected females. (χ2=16.277, p=0.003). Forty per cent (40%) of HIV-infected girls had attained menarche (40%) as against 52.2% in the comparison group but this difference was not statistically significant (χ2=2.705, p=0.100). There was a higher prevalence of pubertal delay in HIV-infected girls (6.7%) compared to non-HIV-infected girls (1.1%). \nConclusion: The mean age of Pubertal onset was significantly later in HIV-infected girls compared to non-HIV-infected. This could have negative implications for psychosocial and reproductive health in HIV-infected girls.","PeriodicalId":14903,"journal":{"name":"Journal of Advances in Medical and Pharmaceutical Sciences","volume":"77 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pubertal Development Pattern in HIV-Infected Girls in Port Harcourt, Southern Nigeria\",\"authors\":\"Azubogu U. S., Ugwu R. O., Jaja T., Alikor E. A.\",\"doi\":\"10.9734/jamps/2023/v25i12660\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Unidentified and untreated pubertal abnormalities in HIV-infected girls may result in adverse psychosocial consequences as well as a reduced final adult height. The aim of the study was to determine the pubertal development pattern in HIV-infected girls receiving care in two tertiary hospitals in Port Harcourt, Southern Nigeria. \\nMaterials and Methods: This was a comparative cross-sectional study involving 90 HIV-infected girls aged 10-18 years and 90 age, sex and socio-economic class matched non-HIV-infected girls. \\nResults: The mean age of pubertal onset in HIV-infected girls was 11.57±1.05 which was significantly higher than the mean age of 10.78±0.69 seen in the non-HIV-infected group (ꭓ 2= 2.667, p=0.011). Sixty three (70%) of HIV-infected females had commenced puberty (Tanner stage 2 or above for breast development) compared to 83 (92.2%) of non-HIV-infected females. (χ2=16.277, p=0.003). Forty per cent (40%) of HIV-infected girls had attained menarche (40%) as against 52.2% in the comparison group but this difference was not statistically significant (χ2=2.705, p=0.100). There was a higher prevalence of pubertal delay in HIV-infected girls (6.7%) compared to non-HIV-infected girls (1.1%). \\nConclusion: The mean age of Pubertal onset was significantly later in HIV-infected girls compared to non-HIV-infected. This could have negative implications for psychosocial and reproductive health in HIV-infected girls.\",\"PeriodicalId\":14903,\"journal\":{\"name\":\"Journal of Advances in Medical and Pharmaceutical Sciences\",\"volume\":\"77 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Advances in Medical and Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/jamps/2023/v25i12660\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advances in Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jamps/2023/v25i12660","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景: 艾滋病病毒感染女童的青春期发育异常如不及时发现和治疗,可能会导致不良的社会心理后果以及成年后身高的降低。本研究旨在确定在尼日利亚南部哈科特港两家三级医院接受治疗的 HIV 感染女童的青春期发育模式。材料与方法:这是一项横断面比较研究,涉及 90 名年龄在 10-18 岁的 HIV 感染女童和 90 名年龄、性别和社会经济阶层相匹配的非 HIV 感染女童。研究结果感染 HIV 的女孩青春期开始的平均年龄为(11.57±1.05)岁,明显高于非 HIV 感染组的平均年龄(10.78±0.69)岁(ꭓ 2= 2.667,P=0.011)。63(70%)名感染艾滋病毒的女性已进入青春期(乳房发育达到或超过坦纳2期),而非感染艾滋病毒的女性为83(92.2%)名。(χ2=16.277,P=0.003)。感染艾滋病毒的女孩中有 40% 达到初潮,而对比组为 52.2%,但差异无统计学意义(χ2=2.705,P=0.100)。与未感染艾滋病毒的女孩(1.1%)相比,感染艾滋病毒的女孩青春期延迟的发生率更高(6.7%)。结论与未感染艾滋病病毒的女孩相比,感染艾滋病病毒的女孩青春期开始的平均年龄明显较晚。这可能会对艾滋病病毒感染女童的社会心理和生殖健康产生负面影响。
Pubertal Development Pattern in HIV-Infected Girls in Port Harcourt, Southern Nigeria
Background: Unidentified and untreated pubertal abnormalities in HIV-infected girls may result in adverse psychosocial consequences as well as a reduced final adult height. The aim of the study was to determine the pubertal development pattern in HIV-infected girls receiving care in two tertiary hospitals in Port Harcourt, Southern Nigeria.
Materials and Methods: This was a comparative cross-sectional study involving 90 HIV-infected girls aged 10-18 years and 90 age, sex and socio-economic class matched non-HIV-infected girls.
Results: The mean age of pubertal onset in HIV-infected girls was 11.57±1.05 which was significantly higher than the mean age of 10.78±0.69 seen in the non-HIV-infected group (ꭓ 2= 2.667, p=0.011). Sixty three (70%) of HIV-infected females had commenced puberty (Tanner stage 2 or above for breast development) compared to 83 (92.2%) of non-HIV-infected females. (χ2=16.277, p=0.003). Forty per cent (40%) of HIV-infected girls had attained menarche (40%) as against 52.2% in the comparison group but this difference was not statistically significant (χ2=2.705, p=0.100). There was a higher prevalence of pubertal delay in HIV-infected girls (6.7%) compared to non-HIV-infected girls (1.1%).
Conclusion: The mean age of Pubertal onset was significantly later in HIV-infected girls compared to non-HIV-infected. This could have negative implications for psychosocial and reproductive health in HIV-infected girls.